Long Beach Medical Center Cardiologists Pioneer Innovative Use of GLP-1 Agonists For decades, GLP-1 agonists—a class of medications including generic names like semaglutide and tirzepatide—have been ...

N EW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...

"While BP is generally linked to negative outcomes, it might be more advantageous for patients to have slightly lower BP as a result of higher HF treatment dosages, than to have higher BP with less HF ...

GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for ...

Heart disease continues to rank as the leading cause of death in the Black community, claiming thousands of lives annually. While lifestyle modifications remain foundational to heart health, modern ...

Heart failure disproportionately affects the black community, with research showing significantly higher rates compared to other populations. While various factors contribute to this disparity, ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

The American College of Cardiology, the American Heart Association and the Heart Failure Society of America released new guidelines Friday that add a fourth class of medication to the recommended ...